Purchase Order N3239825P0121
Award Date
7/31/25
Potential Completion Date
8/2/28
Potential Value
$67K
Federal Agency
Bureau of Medicine and Surgery
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cleveland, OH 44199, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price service contract awarded to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract is for the MiSeq Silver Support Plan, which includes maintenance services for two MiSeq sequencing instruments. The total ceiling value of the contract is $105,192.00, and it has an ultimate completion date of June 23, 2028. The contract was awarded on June 24, 2025 by the Bureau of Medicine and Surgery, a defense...
The U.S. Department of the Navy's Naval Medical Research Command (NMRC) has awarded a firm-fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents, for the procurement of two Illumina MiSeq System instruments. The contract has a total ceiling value of $160,776.00 and an ultimate completion date of June 20, 2024. This sole-source award was made under the authority of 10 U.S.C. 2304(c)(1) and FAR 13.106-1(b)(1), as...
This is a firm fixed price delivery order awarded by the Northeast Area of the federal agency to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $15,078.24 contract is for a MiSeq silver support plan, which provides maintenance and technical support services for Illumina's MiSeq sequencing system. The award does not have a set-aside designation. Illumina has a history of providing a range of sequencing platforms, consumables, and bioinformatics products to...
This is a firm fixed-price federal contract awarded by the Southeast Area of the U.S. Department of [federal agency] to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analysis products. The contract, valued at $16,285.00, is for a service agreement to provide maintenance and support for an Illumina MiSeq sequencing system. The contract was awarded on a sole-source basis, with no set-aside designation. Illumina has a history of providing sequencing instruments, reagents,...
This is a firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for MiSeq maintenance and service. The contract has a ceiling value of $125,421.00 and a period of performance from August 29, 2022, to August 29, 2025. The contract does not have a set-aside designation. Illumina is a manufacturer and provider of genetic and genomic analysis instruments and reagents, and has previously...
This is a firm-fixed-price purchase order awarded by the Naval Medical Research Command to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The requirement is for a MiSeq i100 Plus System, a specialized DNA/RNA sequencing instrument. The $90,997.20 contract has an ultimate completion date of July 30, 2025. Illumina is a prime contractor providing a range of genomic sequencing platforms, reagents, consumables, and maintenance services to multiple federal civilian...
This is a firm fixed price purchase order contract awarded by the Naval Sea Systems Command (NAVSEA), a Defense agency, to Illumina, Inc. The contract has a ceiling value of $69,157.00 and a completion date of August 26, 2021. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, is providing goods and services to support NAVSEA's nucleic acid sequencing needs, including reagents and controls for MiSeq, iSeq, NextSeq, and NovaSeq6000 sequencing platforms used at...
This firm fixed-price delivery order was awarded by the Southeast Area of the U.S. Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $95,931 award is for the provision of an Illumina MiSeq System, a high-throughput DNA sequencing platform, to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. This delivery order is part of a...
This is a firm-fixed-price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of one MiSeq System and a 12-month MiSeq Silver Support Plan, valued at $88,357.50. The contract was awarded on a sole-source basis under the authority of 10 U.S.C. 2304(c)(1), as the Naval Health Research Center requires Illumina's proprietary MiSeq technology for their...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and consumables. The contract is for service and maintenance of an Illumina MiSeq system for fiscal year 2021, with a total ceiling value of $14,070.00. The contract has no set-aside designation. Illumina has received numerous prior federal...